关注
Gary Maartens
Gary Maartens
Professor of Clinical Pharmacology, University of Cape Town
在 uct.ac.za 的电子邮件经过验证
标题
引用次数
年份
'Atypical'bacteria are a common cause of community-acquired pneumonia in hospitalised adults
G Maartens, SJ Lewis, C De Goveia, C Bartie, D Roditi, KP Klugman
South African Medical Journal 84 (10), 678-682, 1994
341994
‘Covering the tail’after stopping efavirenz-based antiretroviral therapy
G Maartens
Southern African Journal of HIV Medicine 21 (1), 2020
12020
2007 Rwanda Service Provision Assessment Survey.[Policy briefing kit].
JM Chakaya, T Young, CE Oliphant, I Araoyinbo, J Volmink, HS Schaaf, ...
East African Medical Journal 85 (11), 521-2, 2008
2008
3rd SA HIV Conference, Durban-track summaries
G Maartens, N Shaikh, F Hassan, K Cullinan, I Meintjes-Moakes, ...
Southern African Journal of HIV Medicine 2007 (28), 8-16, 2007
2007
825 Severe Hepatotoxicity Associated with Nevirapine Use in HIV-Infected
I Sanne, H Mommeja-Marin, J Hinkle, JA Bartlett, MM Lederman, ...
8th IAS Conference on HIV Pathogenesis, Treatment & Prevention 19â 22 July 2015, Vancouver, Canada
KM Pate, C Pohlmeyer, V Walker‐Sperling, J Foote, K Najarro, C Cryer, ...
International AIDS Society, 2015
2015
A clinical prediction rule for PI resistance in resource-limited settings
K Cohen, A Stewart, A Kengne, R Leisegang, M Coetsee, S Maharaj, ...
22nd Conference on Retroviruses and Opportunistic Infections (CROI), 23-26, 2015
12015
A clinical prediction rule for protease inhibitor resistance in patients failing second-line antiretroviral therapy
K Cohen, A Stewart, AP Kengne, R Leisegang, M Coetsee, S Maharaj, ...
JAIDS Journal of Acquired Immune Deficiency Syndromes 80 (3), 325-329, 2019
122019
A clinical prediction score including trial of antibiotics and C-reactive protein to improve the diagnosis of tuberculosis in ambulatory people with HIV
TH Boyles, M Nduna, T Pitsi, L Scott, MP Fox, G Maartens
Open forum infectious diseases 7 (2), ofz543, 2020
152020
A comparative study of the polymerase chain reaction and conventional procedures for the diagnosis of tuberculous pleural effusion
D De Wit, G Maartens, L Steyn
Tubercle and lung disease 73 (5), 262-267, 1992
1401992
A comparison of plasma efavirenz and tenofovir, dried blood spot tenofovir-diphosphate, and self-reported adherence to predict virologic suppression among South African women
TK Phillips, P Sinxadi, EJ Abrams, A Zerbe, C Orrell, NC Hu, K Brittain, ...
JAIDS Journal of Acquired Immune Deficiency Syndromes 81 (3), 311-318, 2019
342019
A comparison of the population pharmacokinetics of rifampicin, isoniazid and pyrazinamide between hospitalized and non-hospitalized tuberculosis patients with or without HIV
N Abdelgawad, M Chirehwa, C Schutz, D Barr, A Ward, S Janssen, ...
Wellcome open research 7, 72, 2022
2022
A machine-learning based model for automated recommendation of individualized treatment of rifampicin-resistant tuberculosis
L Verboven, S Callens, J Black, G Maartens, KE Dooley, S Potgieter, ...
Research square, 2023
32023
A model to rule out smear-negative tuberculosis among symptomatic HIV patients using C-reactive protein
GG Alvarez, E Sabri, D Ling, DW Cameron, G Maartens, D Wilson
The International journal of tuberculosis and lung disease 16 (9), 1247-1251, 2012
202012
A multi-parameter diagnostic clinical decision tree for the rapid diagnosis of tuberculosis in HIV-positive patients presenting to an emergency centre
DJ Van Hoving, G Meintjes, G Maartens, AP Kengne
Wellcome Open Research 5, 2020
32020
A multi-parameter diagnostic clinical decision tree for the rapid diagnosis of tuberculosis in HIV-positive patients presenting to an emergency centre.
D Jacobus, G Meintjes, G Maartens, AP Kengne
2020
A novel Markov model projecting costs and outcomes of providing antiretroviral therapy to public patients in private practices versus public clinics in South Africa
R Leisegang, G Maartens, M Hislop, J Sargent, E Darkoh, S Cleary
PloS one 8 (2), e53570, 2013
142013
A phase 2A trial of the safety and tolerability of increased dose rifampicin and adjunctive linezolid, with or without aspirin, for human immunodeficiency virus–associated …
AG Davis, S Wasserman, C Stek, M Maxebengula, C Jason Liang, ...
Clinical Infectious Diseases 76 (8), 1412-1422, 2023
162023
A randomized controlled trial of intravenous N-acetylcysteine in the management of anti-tuberculosis drug–induced liver injury
MS Moosa, G Maartens, H Gunter, S Allie, MF Chughlay, M Setshedi, ...
Clinical Infectious Diseases 73 (9), e3377-e3383, 2021
352021
A randomized controlled trial of real-time electronic adherence monitoring with text message dosing reminders in people starting first-line antiretroviral therapy
C Orrell, K Cohen, K Mauff, DR Bangsberg, G Maartens, R Wood
JAIDS Journal of Acquired Immune Deficiency Syndromes 70 (5), 495-502, 2015
1132015
系统目前无法执行此操作,请稍后再试。
文章 1–20